| Serial Number | 79423184 |
| Word Mark | VISYNC |
| Filing Date | Thursday, December 12, 2024 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Saturday, February 21, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Surgical, medical and veterinary apparatus and instruments for medical, dental or veterinary use; medical apparatus and instruments, namely, drug delivery devices, sold empty, in the nature of syringes, infusion sets, inhalers and diagnostic apparatus for medical purposes used in medical laboratories for testing blood sugar levels, cancer cells, DNA; diagnostic, examination and monitoring equipment in the nature of imaging equipment, microscopes, blood analysers (haematology analysers), biochemistry analysers, immunoassay analysers, microbiology incubators, centrifuges. |
| Goods and Services | Pharmaceuticals, medical and veterinary preparations all of the foregoing for the prevention, diagnosis, treatment of or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals; biopharmaceutical preparations for the treatment of inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders and advanced therapy medicinal products (atmps), namely, Gene Therapy Medicinal Products (GTMPs), Somatic Cell Therapy Medicinal Products (sCTMPs), Tissue Engineered Products (TEPs), and Combined ATMPs; medicines for human use that are based on genes, tissues or cells for the prevention, diagnosis, treatment of or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management; drugs for medical purposes, namely, pharmaceutical preparations for the prevention, diagnosis, treatment of or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management; pharmaceutical preparations for the prevention, diagnosis, treatment of or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management; biopharmaceutical preparations for the prevention, diagnosis, treatment of or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management and advanced therapy medicinal products (atmps) for systemic or targeted delivery, namely, nasal spray preparations suitable for nasal delivery, nose-to-brain delivery for medical purposes; advanced therapy medicinal products (atmps), namely, Gene Therapy Medicinal Products (GTMPs), Somatic Cell Therapy Medicinal Products (sCTMPs), Tissue Engineered Products (TEPs), and Combined ATMPs, medical and veterinary preparations, namely, medical and veterinary preparations comprising biomolecules, cells, viruses, virus-like particles, exosomes, nanoparticles or liposomes for the prevention, diagnosis, treatment of or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management; vaccines; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic reagents and kits consisting primarily of probes, buffers and reagents for use in microbial testing. |
| Goods and Services | Medical diagnostic services; handling of blood samples in the nature of blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; performing diagnosis of diseases |
| Goods and Services | Scientific and technological consulting services in the pharmaceutical industry and research and design relating thereto; industrial analysis in the nature of product testing, industrial research and industrial design services in the field of pharmaceutical, veterinary and medical goods; quality control of services for others and providing user authentication services using single sign-on technology for online software applications; pharmaceutical and biological analysis and research services; medical research relating to the research, development and manufacturing activities in the field of medicines, namely biomolecules, cells, viruses, virus-like particles, exosomes, nanoparticles, liposomes and vaccines; medical research relating to the research, development and manufacturing activities in the field of delivery of medicines namely, nasal spray preparations suitable for nasal delivery, nose-to-brain delivery; technological research being research and development of manufacturing processes for the pharmaceutical industry; optimization of processes in the nature of technological consultancy services for search engine optimization for the pharmaceutical industry; design and development of medical diagnostic apparatus for detecting inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; scientific research for medical purposes in the area of inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 8, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 8, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 8, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 8, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | VISYNC TECHNOLOGIES, S.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 84 - NOT AVAILABLE |
| Address | PT |
| Event Date | Event Description |
| Thursday, May 8, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, May 9, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 9, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, May 30, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, June 4, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, June 5, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, July 28, 2025 | REFUSAL PROCESSED BY MPU |
| Monday, July 28, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, August 16, 2025 | REFUSAL PROCESSED BY IB |
| Wednesday, January 28, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 28, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 28, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, February 21, 2026 | FINAL REFUSAL WRITTEN |
| Saturday, February 21, 2026 | FINAL REFUSAL E-MAILED |
| Saturday, February 21, 2026 | NOTIFICATION OF FINAL REFUSAL EMAILED |